Drugs / HIV immune globulin solution
HIV immune globulin solution
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00639938 | Jul 2004 → Jul 2007 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HIV immune globulin solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00639938 ↗ |
| Modality | Protein / enzyme biologic | “HIV hyperimmune globulin” PMID 21826009 ↗ Dec 2011 |
| Route | Intravenous | “12 gm intravenous dose of HIVIGLOB” NCT00639938 ↗ |